Refresh

Zydus Lifesciences Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release


Download
28 Jun 2024
Zydus and Dr. Reddy''s announce licensing agreement for co-marketing of Pertuzumab biosimilar, a critical treatment for breast cancer patients in India.

Source: BSE India

View all announcements for Zydus Lifesciences Ltd
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com